Company intelligence / Profile preview
Globin Solutions, Inc.
Pittsburgh, Pennsylvania, United Statesglobinsolutions.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Globin Solutions has developed a lead recombinant neuroglobin compound as a rapidly acting intravenous antidote for carbon monoxide poisoning. The company has completed significant preclinical work, including manufacturing optimization and safety testing in animals. It has received NIH STTR funding to advance its program toward clinical trials[2][3][4][5].
- Therapeutic areas
- OtherPulmonology
- Modalities
- Recombinant proteinsModified hemoglobin-based moleculesHeme-based solutions
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
University of Pittsburgh (sponsored research agreements)[2][3]Tus S&T Service Group / Tus Science & Technology Service Group of China (investor/partner)[2][5]UPMC Enterprises (investor/partner)[2][5]
Beyond the preview
Go deeper on Globin Solutions, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Globin Solutions, Inc..